‘No insulin or medication’: electronic device regulates blood sugar and reduces weight

Screenshot 2026-11-19 110810
AI Generated Image
  • +
  • -
In a scientific development that could open a new path for treating type 2 diabetes, Swiss researchers have created an electronic implant that uses electricity to convert excess blood sugar into a substance the body can eliminate through urine, instead of relying on insulin or conventional medicines.اضافة اعلان

Initial experiments on diabetic mice showed the device helped regulate glucose levels, and its use was also linked to weight loss. The study’s findings were published in the journal Science, according to a research team from the Swiss Federal Institute of Technology in Zurich (ETH Zurich).

A treatment that handles excess sugar differently
The study was led by Martin Fussenegger, Professor of Biosystems Science and Engineering, who explained that insulin helps lower blood sugar by facilitating the movement of glucose into muscle cells, but it does not get rid of excess energy, which can turn into fat if it is not used.

The team therefore developed a technology that targets excess glucose directly, converting it into a substance called gluconate, which the body can excrete in urine.

The device relies on a catalyst made entirely of inorganic materials, with no living cells, enzymes or biological components. This may reduce some of the challenges linked to immune compatibility and long-term stability.
Gold and platinum to drive the chemical reactionThe implant consists of a piece of graphite felt covered with tiny clusters of gold, and coated with smaller particles of platinum. This nanoscale surface enables the chemical reaction needed to convert glucose. The device includes an electronic control unit inside a casing made with 3D printing, and receives power wirelessly at a frequency of 13.56 megahertz.

The system is also linked to a sensor that continuously measures glucose levels. When levels rise above the target, the sensor sends a signal to a smartphone or smartwatch, which activates the implant and supplies it with the energy it needs. The process stops automatically when blood sugar returns to the target range.

This system, known as “closed-loop control”, is designed to respond to changes in blood sugar and to prevent glucose from continuing to be converted after its levels have dropped.

Blood sugar control and weight loss in early trialsThe researchers first tested the device in a tank containing five litres of nutrient solution and glucose, before moving on to experiments on diabetic mice.

The results showed the implant’s ability to control blood sugar levels in the animals, along with weight loss. The researchers suggest that converting part of the excess glucose into gluconate, rather than leaving it available for storage, may explain this metabolic benefit.

The device operated reliably for six weeks, and the animals tolerated it well. Fussenegger said the experiments revealed no tissue damage from electrical or thermal effects.

Will the innovation reach diabetes patients?Despite the promising results, the technology is still at the preclinical stage and has not yet been tested on humans. The researchers are working to develop the implant into a medical device that can move on to clinical trials.

The team believes that relying on electronic components and a non-biological catalyst will make the device easier to manufacture and develop on a large scale, particularly given the availability of wireless power transfer technologies and electronic control units. generate interesting image for this article